Study of Oral Fampridine-SR in Multiple Sclerosis
Public ClinicalTrials.gov record NCT00127530. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the safety and efficacy of 10 milligram (mg) twice a day (b.i.d.) Fampridine-SR in patients diagnosed with multiple sclerosis (MS), in a double-blind, placebo-controlled, parallel group study.
Study identification
- NCT ID
- NCT00127530
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2005 (Type not available)
- Primary completion
- Jun 2006 (Actual)
- Completion
- Sep 2006 (Actual)
- Last update posted
- Sep 11, 2018
2005 – 2006
United States locations
- U.S. sites
- 30
- U.S. states
- 22
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35233 | — |
| Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| USC, Keck School of Medicine | Los Angeles | California | 90033 | — |
| UC Davis | Sacramento | California | 95817 | — |
| University of Colorado Health Sciences Center | Denver | Colorado | 80262 | — |
| Multiple Sclerosis Treatment Center | Derby | Connecticut | 06418 | — |
| Shepard Center | Atlanta | Georgia | 30309 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Indiana University MS Center | Indianapolis | Indiana | 46202 | — |
| Maryland Center for MS | Baltimore | Maryland | 21201 | — |
| Wayne State University, Department of Neurology | Detroit | Michigan | 48201 | — |
| The Schapiro Center for MS | Golden Valley | Minnesota | 55422 | — |
| Washington University SOM | St Louis | Missouri | 63110 | — |
| Gimbel MS Center at Holy Name Hospital | Teaneck | New Jersey | 07666 | — |
| University of Mexico, MIND Imaging Center | Albuquerque | New Mexico | 87131 | — |
| Maimonides Medical Center | Brooklyn | New York | 11220 | — |
| Corinne Goldsmith Dickinson Center for MS | New York | New York | 10029 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| SUNY - Stony Brook | Stony Brook | New York | 11794 | — |
| Carolinas Healthcare System | Charlotte | North Carolina | 28207 | — |
| Cleveland Clinical Foundation | Cleveland | Ohio | 44095 | — |
| Ohio State University MS Center | Columbus | Ohio | 43221 | — |
| Oregon Health & Science University, MS Center of Oregon, UHS-42 | Portland | Oregon | 97239 | — |
| Thomas Jefferson University Physicians | Philadelphia | Pennsylvania | 19107 | — |
| Allegheny General Hospital, Allegheny Neurological Associates | Pittsburgh | Pennsylvania | 15212 | — |
| University of Texas - Houston | Houston | Texas | 77030 | — |
| Neurological Research Center, Inc. | Bennington | Vermont | 05201 | — |
| Fletcher Allen Health Care | Burlington | Vermont | 05401 | — |
| MS Hub Medical Group | Seattle | Washington | 98101 | — |
| University of Washington, MS Research Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00127530, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00127530 live on ClinicalTrials.gov.